Published 07 Jul 2020

Qure.ai won FDA clearance for its AI-powered head CT scanning tool

SHARE

https://cms.qure.ai
Mumbai-based AI startup Qure.ai has received FDA clearance for its head CT scan tool, qER, designed to assist radiologists in triaging patients. The AI-powered platform prioritizes urgent cases like intracranial bleeds to improve diagnosis speed and efficiency. Radiologists, who interpret an image every 3-4 seconds during an eight-hour workday, could significantly benefit from Qure.ai's automated detection tool, reducing their workload and improving patient care.
In the context of the pandemic, AI-powered diagnostic tools like qER have gained considerable importance. Startups like Qure.ai and Aidoc have launched software facilitating coronavirus diagnoses, signaling a potential surge in AI adoption within radiology.
The American Hospital Association predicts over $200 billion in losses for U.S. hospitals this year due to canceled elective procedures. Despite tighter investment budgets, hospitals are likely to continue investing in need-to-have AI tools that can enhance diagnostics and reduce costs, both in combating COVID-19 and in resuming elective procedures.

Share this story

Featured in

image 30.svg
image 26.svg
livemint logo.svg
image 29.svg
image 28.svg
image 31.svg
image 27.svg
image 30.svg
image 26.svg
livemint logo.svg
image 29.svg
image 28.svg
image 31.svg
image 27.svg